CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The Tune-IT project focuses on improving adoptive cell therapy for cancer treatment by developing a novel platform for expanding T cells. This technology aims to enhance T cell function and longevity, addressing challenges in current therapies.
Adoptive cell therapy (ACT) recently became an important treatment modality for cancer .
Since 2017, several chimeric antigen receptor (CAR)-T cell therapies approved by the FDA/EMA and more are expected to receive approval for clinical use.
Currently, more than 250 clinical ACT trials are ongoing.
Already in 2021, the market size was >$1 billion and is expected to grow tremendously to >$25 billion by 2030. ACT products require extensive ex vivo manipulation and expansion of patient derived T…
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
